Pmv Pharmaceuticals, Inc.

Pmv Pharmaceuticals, Inc. company information, Employees & Contact Information

Explore related pages

Pmv Pharmaceuticals, Inc. email format Pmv Pharmaceuticals, Inc. management contacts

Related company profiles:

At PMV, we believe that by specifically targeting each mutant p53 we can fundamentally disrupt the course of cancer. Our research and development efforts are dedicated to selectively targeting mutant p53, providing unique therapies for any patient whose tumor harbors these gene mutations.

Company Details

Employees
72
Founded
-
Address
400 Alexander Park,
Email
in****@****rma.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Website
pmvpharma.com
Keywords
motivations that drive them to make a difference in the fight against cancer..
HQ
Princeton, New Jersey
Competitors
Allakos Inc, Vertex Pharmaceuticals, Arcus Biosciences, PTC Therapeutics, Inc., Ikena Oncology, Legend Biotech, Novartis, Chiara Biosciences, Taro Pharmaceutical Industries, Insmed Incorporated.
Looking for a particular Pmv Pharmaceuticals, Inc. employee's phone or email?

Pmv Pharmaceuticals, Inc. Questions

News

PMV Pharma Presents Promising Phase 2 Trial Results for Rezatapopt at 2025 AACR-NCI-EORTC Conference - Quiver Quantitative

PMV Pharma Presents Promising Phase 2 Trial Results for Rezatapopt at 2025 AACR-NCI-EORTC Conference Quiver Quantitative

Initial PYNNACLE Phase 2 analysis — PMV Pharma to present rezatapopt data on TP53 Y220C at AACR - Stock Titan

Initial PYNNACLE Phase 2 analysis — PMV Pharma to present rezatapopt data on TP53 Y220C at AACR Stock Titan

PMV Pharmaceuticals Reports Second Quarter 2025 Financial Results and Corporate Highlights - GlobeNewswire

PMV Pharmaceuticals Reports Second Quarter 2025 Financial Results and Corporate Highlights GlobeNewswire

PMV Pharmaceuticals, Inc. to Host Investor Webinar on Phase 2 PYNNACLE Clinical Trial Interim Analysis on September 10, 2025 | PMVP Stock News - Quiver Quantitative

PMV Pharmaceuticals, Inc. to Host Investor Webinar on Phase 2 PYNNACLE Clinical Trial Interim Analysis on September 10, 2025 | PMVP Stock News Quiver Quantitative

PMV Pharma to Reveal Phase 2 PYNNACLE Trial Results: 65 Cancer Patients, $148M Cash Through 2026 - Stock Titan

PMV Pharma to Reveal Phase 2 PYNNACLE Trial Results: 65 Cancer Patients, $148M Cash Through 2026 Stock Titan

PMV Pharmaceuticals Reports Full Year 2024 Financial Results and Corporate Highlights - GlobeNewswire

PMV Pharmaceuticals Reports Full Year 2024 Financial Results and Corporate Highlights GlobeNewswire

Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezatapopt, a First-In-Class, Investigational, Selective p53 Y220C Reactivator - Yahoo Finance

Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezatapopt, a First-In-Class, Investigational, Selective p53 Y220C Reactivator Yahoo Finance

PMV Pharmaceuticals Strengthens Leadership with Key Appointments - citybiz

PMV Pharmaceuticals Strengthens Leadership with Key Appointments citybiz

PMV Pharmaceuticals Announces Oral Presentation of Initial Data from Phase 2 Study of Rezatapopt for TP53 Y220C Mutant Advanced Solid Tumors at AACR-NCI-EORTC Conference - Quiver Quantitative

PMV Pharmaceuticals Announces Oral Presentation of Initial Data from Phase 2 Study of Rezatapopt for TP53 Y220C Mutant Advanced Solid Tumors at AACR-NCI-EORTC Conference Quiver Quantitative

33% Response Rate Across 8 Cancer Types: PMV Pharma's Breakthrough TP53 Drug Shows Promise in Phase 2 Trial - Stock Titan

33% Response Rate Across 8 Cancer Types: PMV Pharma's Breakthrough TP53 Drug Shows Promise in Phase 2 Trial Stock Titan

PMV Pharmaceuticals to Present Rezatapopt Pivotal Phase 2 Initial Analysis and Natural History Study Results at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics - GlobeNewswire

PMV Pharmaceuticals to Present Rezatapopt Pivotal Phase 2 Initial Analysis and Natural History Study Results at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics GlobeNewswire

PMV Pharma (NASDAQ: PMVP) shows 34% ORR in Phase 2 PYNNACLE, 7.6-month DOR - Stock Titan

PMV Pharma (NASDAQ: PMVP) shows 34% ORR in Phase 2 PYNNACLE, 7.6-month DOR Stock Titan

PMV Pharmaceuticals Reports First Quarter 2025 Financial Results and Corporate Highlights - GlobeNewswire

PMV Pharmaceuticals Reports First Quarter 2025 Financial Results and Corporate Highlights GlobeNewswire

PMV Pharmaceuticals Provides a Progress Update on PYNNACLE Clinical Trial - GlobeNewswire

PMV Pharmaceuticals Provides a Progress Update on PYNNACLE Clinical Trial GlobeNewswire

Companies like Pmv Pharmaceuticals, Inc.

Allakos Inc logo - Similar company to Pmv Pharmaceuticals, Inc.

Allakos Inc

41
Ikena Oncology logo - Similar company to Pmv Pharmaceuticals, Inc.

Ikena Oncology

22
Legend Biotech logo - Similar company to Pmv Pharmaceuticals, Inc.

Legend Biotech

2.14K
Vertex Pharmaceuticals logo - Similar company to Pmv Pharmaceuticals, Inc.

Vertex Pharmaceuticals

6.09K
Chiara Biosciences logo - Similar company to Pmv Pharmaceuticals, Inc.

Chiara Biosciences

7
Arcus Biosciences logo - Similar company to Pmv Pharmaceuticals, Inc.

Arcus Biosciences

680
Novartis logo - Similar company to Pmv Pharmaceuticals, Inc.

Novartis

79.78K
PTC Therapeutics, Inc. logo - Similar company to Pmv Pharmaceuticals, Inc.

Ptc Therapeutics, Inc.

1.18K
Taro Pharmaceutical Industries logo - Similar company to Pmv Pharmaceuticals, Inc.

Taro Pharmaceutical ...

148
Insmed Incorporated logo - Similar company to Pmv Pharmaceuticals, Inc.

Insmed Incorporated

1.47K

Top Pmv Pharmaceuticals, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant